Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (4752)	7/6/1998 1:53:00 PM
From: Izzy	Read Replies (2) of 6136

Steve (and others): Do the July 30 (3/8) and Aug 30 (1 1/2) calls look any good to you? I don't see any new "put" volume. I'm trying to figure out if it's cheaper to buy the stock outright or jump on the "calls"; that is, what's my best bet for ROI at this time? IMO, this stock has to be oversold. Altho' MS has lowered projected earnings (doesn't surprise me any; I had mentioned this possibility on at least 2 prior posts) but there has been no "downgrade" of the stock. IMO, even AGPH thinks that the price drop is an "over-reaction." Any ideas or suggestions out there for now? Thanks.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next